Bravura Solutions Limited (ASX:BVS – Get Rating) insider Peter Mann purchased 85,707 shares of the business’s stock in a transaction dated Wednesday, April 12th. The shares were purchased at an average cost of A$0.42 ($0.28) per share, for a total transaction of A$36,168.35 ($24,274.06). Peter Mann also recently made the following trade(s): On Friday, March […]
Bioventus (NYSE:BVS – Get Rating) and Modular Medical (OTC:MODD – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership. Volatility & Risk Bioventus has a beta of 0.48, meaning […]
Bravura Solutions Limited (ASX:BVS – Get Rating) insider Peter Mann acquired 126,500 shares of the stock in a transaction that occurred on Friday, March 17th. The stock was purchased at an average price of A$0.35 ($0.23) per share, for a total transaction of A$44,275.00 ($29,714.77). Bravura Solutions Price Performance The company has a current ratio […]
Bravura Solutions Limited (ASX:BVS – Get Rating) insider Peter Mann acquired 126,500 shares of the company’s stock in a transaction on Friday, March 17th. The stock was bought at an average cost of A$0.35 ($0.23) per share, with a total value of A$44,275.00 ($29,714.77). Bravura Solutions Stock Performance The company has a quick ratio of […]
Bioventus (NYSE:BVS – Get Rating) issued its earnings results on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.01), MarketWatch Earnings reports. Bioventus had a return on equity of 21.93% and a net margin of 2.67%. During the same period in the prior year, […]